Clinical activity and safety of sintilimab, bevacizumab, and TMZ in patients with recurrent glioblastoma.

Autor: Lu, Yinghao1 (AUTHOR), Liao, Limin1 (AUTHOR), Du, Kunpeng1 (AUTHOR), Mo, Jianhua2 (AUTHOR), Zou, Xia2 (AUTHOR), Liang, Junxian3 (AUTHOR), Chen, Jiahui1 (AUTHOR), Tang, Wenwen1 (AUTHOR), Su, Liwei1 (AUTHOR), Wu, Jieping1 (AUTHOR), Zhang, Junde1 (AUTHOR) 13002087575@163.com, Tan, Yujing1 (AUTHOR) tanyujing-1981@163.com
Zdroj: BMC Cancer. 1/25/2024, Vol. 24 Issue 1, p1-10. 10p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje